0001209191-19-006630.txt : 20190201
0001209191-19-006630.hdr.sgml : 20190201
20190201202527
ACCESSION NUMBER: 0001209191-19-006630
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20190201
FILED AS OF DATE: 20190201
DATE AS OF CHANGE: 20190201
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Howton David T
CENTRAL INDEX KEY: 0001529297
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-14895
FILM NUMBER: 19561414
MAIL ADDRESS:
STREET 1: VERTEX PHARMACEUTICALS INCORPORATED
STREET 2: 130 WAVERLY STREET
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Sarepta Therapeutics, Inc.
CENTRAL INDEX KEY: 0000873303
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 930797222
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 215 FIRST STREET
STREET 2: SUITE 415
CITY: CAMBRIDGE
STATE: MA
ZIP: 02142
BUSINESS PHONE: 617-274-4000
MAIL ADDRESS:
STREET 1: 215 FIRST STREET
STREET 2: SUITE 415
CITY: CAMBRIDGE
STATE: MA
ZIP: 02142
FORMER COMPANY:
FORMER CONFORMED NAME: Sarepta Therapuetics, Inc.
DATE OF NAME CHANGE: 20120712
FORMER COMPANY:
FORMER CONFORMED NAME: AVI BIOPHARMA INC
DATE OF NAME CHANGE: 19980930
FORMER COMPANY:
FORMER CONFORMED NAME: ANTIVIRALS INC
DATE OF NAME CHANGE: 19970123
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2019-02-01
0
0000873303
Sarepta Therapeutics, Inc.
SRPT
0001529297
Howton David T
215 FIRST STREET, SUITE 415
CAMBRIDGE
MA
02142
0
1
0
0
SVP, General Counsel
Common Stock
2019-02-01
4
M
0
3125
13.71
A
31196
D
Common Stock
2019-02-01
4
M
0
1548
13.71
A
32744
D
Common Stock
2019-02-01
4
M
0
16827
23.85
A
49571
D
Common Stock
2019-02-01
4
S
0
30000
140.00
D
19571
D
Stock Option (right to buy)
13.71
2019-02-01
4
M
0
3125
13.71
D
2017-02-28
2026-02-28
Common Stock
3125
6965
D
Stock Option (right to buy)
13.71
2019-02-01
4
M
0
1548
13.71
D
2016-09-19
2025-09-19
Common Stock
1548
5883
D
Stock Option (right to buy)
23.85
2019-02-01
4
M
0
16827
23.85
D
2013-11-05
2022-11-05
Common Stock
16827
116405
D
This transaction was effected pursuant to a Rule 10b5-1 Plan. Accordingly, the reporting person had no discretion with regards to the timing of the transaction.
/s/ David Tyronne Howton
2019-02-01